GlassScriptPhysician profile
Ferenc P Nagy
NPI 1457560302
$47,393.06
in general payments reported to CMS, 2019-2025
17 companies · $6,439 in 2025
The $6,439 reported for 2025 was more than what 87% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,617 · 2020: $243 · 2021: $8,748 · 2022: $7,201 · 2023: $7,655 · 2024: $14K · 2025: $6,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $4,886 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,600 · Travel and Lodging: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,250.00 |
| Food and Beverage | $4,885.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,600.00 |
| Travel and Lodging | $1,847.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $31,725.78 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $8,796.44 | 2019-2025 | Enroute .014" Guidewire, Eluvia, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $4,124.89 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Penumbra, INC. | $842.54 | 2022-2025 | Indigo System, Penumbra System |
| Abbott Laboratories | $458.53 | 2019-2025 | Esprit |
| Terumo Medical Corporation | $307.55 | 2019-2021 | |
| Endologix LLC | $304.05 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $163.04 | 2022-2023 | Endurant Iis |
| Bolton Medical INC | $134.12 | 2022 | |
| Medtronic Vascular, INC. | $131.18 | 2019-2020 | |
| Ekos Corporation | $129.11 | 2019 | |
| Angiodynamics, INC. | $117.06 | 2022 | |
| Cook Medical LLC | $69.61 | 2019 | |
| Cvrx, INC. | $28.78 | 2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $25.49 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $18.39 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ferenc Nagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.